NHS England has today pledged a £160m boost over two years for the Cancer Drugs Fund, giving more patients access to innovative drugs not routinely available on the NHS. Two new drugs will now also be added to the Fund; enzalutamide for prostate cancer and lenalidomide for a group of patients with myelodysplastic syndrome, a […]
The UK is set to become the world leader in ground-breaking genetic research into cancer and rare diseases, which will transform how diseases are diagnosed and treated, thanks to£300million of investment, the Prime Minister announced today (1 August). The four year project will allow scientists to do pioneering new research to decode 100,000 human genomes […]
NHS England Essex today publishes its report into the safety of five cancer services at Colchester Hospital University NHS Foundation Trust (CHUFT). The Incident Management Team (IMT) – set up to undertake the review – is reporting on its findings relating to five cancer pathways at the Trust: Brain and Central Nervous System; Cancer of […]
NHS England is supporting a campaign launched by The Sunday Times newspaper, which aims at improving cancer care. The campaign focuses on swifter diagnosis, faster and more consistent treatment across the country and more advanced radiotherapy. National Medical Director, Professor Sir Bruce Keogh, said NHS England has ambitions to raise cancer survival to match the […]
Nine hundred cancer patients every year could benefit from three new drugs which have been added to the Cancer Drugs Fund. The drugs Albumin Bound Paclitaxel, Bevacizumab and Cabozantinib are to be used to treat pancreatic cancer, brain tumours in children and thryroid cancer respectively. Albumin Bound Paclitaxel(this document is no longer available here but […]
Five hundred women every year could benefit from a new drug which has been added to the Cancer Drugs Fund to treat advanced cervical cancer. The drug bevacizumab (Avastin) is already used in the treatment of other cancers, however this is the first time it will be available on the Cancer Drugs Fund (CDF) for […]
NHS England has released an update to the national Cancer Drugs Fund list, further increasing access for patients to an additional three new cancer drugs. The additions to the list have been made following a review of trial data from the drugs by the Chemotherapy Clinical Reference Group (CRG), one of 74 such groups which […]
NHS England on behalf of the Incident Management Team today publishes the findings of its review of cancer services at Colchester Hospital University NHS Foundation Trust. The primary aim of the immediate review was to answer the question “Are the cancer services safe?” The Review took place between the 14th November and the 9th December […]
Improving Outcomes: Strategy for Cancer was published in January 2011 with the ambition to save an additional 5000 lives a year by 2014/15 and halve the gap between England and the best in Europe for survival rates. Today (10 December) the third annual report on the progress of implementation of the strategy is published. This […]
Teams of cancer specialists and other senior clinicians have begun reviews of services for every type of cancer at Colchester Hospital University NHS Foundation Trust. The review teams, which are independent of the Trust, are being co-ordinated by an NHS England-led Incident Management Team. They are examining all 14 cancer pathways at the Trust. The […]